Literature DB >> 29285598

Diagnosis of Budd-Chiari syndrome.

Morgane Van Wettere1, Onorina Bruno1, Pierre-Emmanuel Rautou2, Valérie Vilgrain1,3,4, Maxime Ronot5,6,7.   

Abstract

Budd-Chiari syndrome (BCS) is defined by clinical and laboratory signs associated with partial or complete impairment of hepatic venous drainage in the absence of right heart failure or constrictive pericarditis. Primary BCS is the most frequent type and is a complication of hypercoagulable states, in particular myeloproliferative neoplasms. Secondary BCS involves tumor invasion or extrinsic compression. Most patients present with chronic BCS including a non-cirrhotic, dysmorphic, chronic liver disease with various degrees of fibrosis deposition. Acute BCS is rare, and patients present with hepatomegaly, ascites, and hepatic insufficiency. The diagnosis is based on imaging. Imaging features include (1) direct signs, in particular occlusion or compression of the hepatic veins and/or the inferior vena cava and venous collaterals and (2) indirect signs, in particular morphological changes in the liver with hypertrophy of the caudate lobe and delayed nodule formation. Ultrasound and magnetic resonance imaging are the gold standard for diagnosis. The aim of this review is to provide an overview of the role of imaging in the diagnosis of BCS.

Entities:  

Keywords:  Prothrombotic state; Thrombosis; Vascular liver disorder; Vein

Mesh:

Year:  2018        PMID: 29285598     DOI: 10.1007/s00261-017-1447-2

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  6 in total

1.  Budd-Chiari syndrome: a focussed and collaborative approach.

Authors:  Amar Mukund; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2018-10-08       Impact factor: 6.047

2.  Chronic abdominal pain and Budd-Chiari syndrome: A relentless quest for an underlying neoplastic etiology.

Authors:  Natasha Chandok; Said Ishmail; Jeffrey Jaskolka; Sanjeev Sirpal
Journal:  Can Liver J       Date:  2022-08-16

Review 3.  The digestive system involvement of antiphospholipid syndrome: pathophysiology, clinical characteristics, and treatment strategies.

Authors:  Jin Zhang; Cheng Li; Xiaorong Han; Zhongbo Chen; Binay Kumar Adhikari; Yinghui Wang; Yonggang Wang; Jian Sun
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

Review 4.  Budd-Chiari syndrome: imaging review.

Authors:  Varun Bansal; Pankaj Gupta; Saroj Sinha; Narender Dhaka; Naveen Kalra; Rajesh Vijayvergiya; Usha Dutta; Rakesh Kochhar
Journal:  Br J Radiol       Date:  2018-07-24       Impact factor: 3.039

5.  Changes and significance of hydrodynamic parameters in Budd-Chiari syndrome with obstruction of the inferior vena cava prior to and after interventional therapy.

Authors:  Lulu Lyu; Peng Xu; Jie Ping; Chunfeng Hu; Kai Xu
Journal:  Exp Ther Med       Date:  2021-01-05       Impact factor: 2.447

Review 6.  State of the Art, Current Perspectives, and Controversies of Budd-Chiari Syndrome: A Review.

Authors:  Paschalis Gavriilidis; Gabriele Marangoni; Jawad Ahmad; Daniel Azoulay
Journal:  J Clin Med Res       Date:  2022-04-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.